M I N G YA N & P H I L S . B A R A N
P athogenic bacteria have developed strong resistance to various antibiotics as a result of the rapid evolution of the bacteria in response to widespread antibiotic misuse. This problem is exacerbated by the reduction in antibacterial-drug research by large pharmaceutical companies over the past few decades -we are failing to replenish our armamentarium quickly enough to compensate. An apocalyptic scenario looms wherein a drug-resistant 'superbug' becomes so well established that the most trivial infections would be as life-threatening as they were during the pre-antibiotic era. On page 338 of this issue, Seiple et al. 1 offer an ingenious strategy to bolster the antibiotic-discovery process: a highly modular and versatile chemicalsynthesis approach that provides access to a rich array of antibiotics possessing different molecular topologies and functionalities.
Naturally occurring compounds derived from bacteria or fungi have long been the primary source of antibiotics. These compounds can be produced on a large scale by fermentation, but few inherently possess adequate bio availability, in vivo activity or metabolic stability for use as drugs 2 . Chemical modifications are often necessary to address these issues. The complexity of natural products means that such modifications often involve a long, linear sequence of steps in which chemical groups in the molecules are masked with 'protecting' groups to allow the modifications to be made, and then unmasked. Making variations at certain molecular locations tends to be particularly laborious or impractical, and so synthesizing a diverse collection of antibiotic candidates for drug discovery can be forbiddingly difficult.
Seiple and colleagues show convincingly that chemical synthesis can surmount the challenge of molecular diversification, trumping strategies based on synthetic biology 3 or semisynthesis (in which compounds from natural sources are used as starting materials). In their approach, the authors constructed complex macrolides -antibiotics that contain a characteristic large ring of atoms known as a macrocycle -through the assembly of eight modular building blocks. These simple modules could each be varied easily to incorporate different structural motifs at specific locations in the macrolide skeleton.
The researchers' synthetic route included seven key coupling reactions, each of which introduced different building blocks into the macrolide (Fig. 1) . Such reactions are said to be convergent because they bring together modules that were prepared in separate, parallel reaction sequences. The convergent coupling reactions serve as branch points in the synthesis that allow a diverse range of structural modifications to be easily made. For example, Seiple et al. introduced reactive groups such as azides, allyl groups and amides at different positions, all of which could be readily converted into various structural motifs. Such manipulation, when combined with variations in the building blocks, enables an exponential expansion of diversity.
This approach is possible only because the synthetic sequence is extremely well choreographed. Steps such as protecting-group manoeuvres are kept to a minimum; convergent couplings and other complexity-building transformations account for the bulk of the sequence. These key reactions are mechanistically very different from one another (ranging between the addition of an enolate and a transition-metal-catalysed cycloaddition, for those in the know). Yet the authors show that these all work well for modules that carry a variety of groups.
The formation of macrocyclic rings is one of the toughest challenges in macrolide synthesis -many routes to these antibiotics are foiled because attempts to form the ring fail 4 . Conventionally, macrocycle formation must be individually optimized for each reaction substrate by finding a set of protecting groups that allows the transformation to occur. However, Seiple and colleagues report that, in their work, macrolides containing various ring sizes can be made using almost identical ring-formation conditions.
Similarly, other reactions in the synthetic sequence need minimal adaptation to work for different substrates that contain a variety of chemical groups, and deliver consistent yields of products. Such generality is the corner stone of the authors' approach, because it allows hundreds of analogues of macrolides, bearing highly dissimilar arrangements of attached groups, to be accessed expeditiously with little perturbation to the overall strategy.
Another prerequisite for rapidly generating structural diversity is an abundant supply of diversifiable intermediates; this in turn requires all the chemical transformations in the syntheses to be conducted on gram scales 5 . Seiple et al. tackled this challenge using a series of in-house methodologies. The first was a scalable aldol reaction, a type of carbon-carbon bond-forming reaction. This reaction shows exceptional stereoselectivity (it preferentially forms isomers that have specific 3D orientations of atoms) and tolerates the presence of a potentially interfering amino group (NH 2 ) in one of the reactants 6 . The second was a concise approach 7 to preparing the carbohydrate desosamine and its analogues, which form a key part of another building block. These 1 report a synthetic route that allows the rapid preparation of a diverse array of structural analogues of macrolide antibiotics. The authors prepared eight modular building blocks (coloured shapes), the structures of which can be easily modified. The synthetic route includes seven key steps in which the building blocks are joined together. Chemical groups in the modules can also be readily converted into various other groups after the modules have been incorporated into macrolide intermediates (not shown). This approach allowed the authors to prepare more than 300 macrolides, including the clinical candidate solithromycin. examples highlight the synergy between target-oriented synthesis and methodology developments.
Using such scalable methods allowed the authors to make gram quantities of several macrolides -a large amount for drugdiscovery purposes -in remarkably high overall yields. This reaffirms the fact that scalable synthetic methods that can provide ample supplies of structural analogues of molecules are essential for the continued success of drug discovery 4 . Given the sheer number of possible macrolide analogues, some structural variations will remain challenging to produce synthetically, but further advances in synthetic methods will probably bridge the gaps.
Impressively, Seiple and colleagues prepared more than 300 macrolide antibiotics as candidates for pharmaceutical development. The researchers report that most of these compounds inhibit the growth of drug-resistant pathogens, including some extremely challenging strains. Further studies are necessary for assessing properties (such as toxicity and bioavailability) that will affect the antibiotics' clinical viability, but these compounds represent a gateway to commercial pharmaceuticals. One of the compounds is more effective against Gram-negative bacteria than are many other macro lides. Its activity is still modest, but marks a promising start to tackling an important medical need.
No antibiotic is impervious to the power of evolution -bacteria will always mutate to develop resistance, which means that new antibiotics must be pursued continuously and perpetually. To this end, synthetic platforms such as the present one offer rapid access to unparalleled structural variability for anti biotic candidates, while still allowing exquisite control of each variation. This fine-tunability, along with biological knowledge, can enable chemists to keep up with bacterial evolution. In the midst of the antibiotic-resistance crisis, Seiple 
A deliberate mix-up in flavour
Neutrinos come in three 'flavours', as do antineutrinos, and they all change flavour as they travel. New measurements of the mixing of different neutrinos may help to explain why our Universe is made of matter and not antimatter.
H E L E N O ' K E E F F E
F or decades, physicists have been intrigued as to why the visible Universe is made of matter, rather than antimatter. Intuitively, studying the smallest of the known fundamental particles, the neutrino, may reveal the answer to this question. As neutrinos travel through space and time, they can oscillate between three different types (flavours). If the way in which antineutrinos change flavour differs from the way neutrinos change flavour, these relatively small differences may have led to a matter-based Universe.
Experiments have been set up to study the amplitude and frequency of these changes to determine the measurable parameters associated with flavour oscillations, such as mass differences (neutrinos have three possible masses, denoted 1, 2 and 3) and mixing angles (how much mixing occurs between neutrinos of mass 1, 2 and 3). Writing in Physical Review D, the Daya Bay Collaboration 1 reports that it has used a new detection method to make the most precise measurement yet of θ 13 , the mixing angle between neutrino mass 1 and neutrino mass 3. This will help in our quest to understand the origin of the dominance of matter in the Universe.
The Daya Bay experiment is located on the southern coast of China, approximately 55 kilo metres northeast of Hong Kong. The site consists of eight identical antineutrino detectors, located between 360 m and 1.9 km from the Daya Bay and Ling Ao nuclear power plants. Approximately 3,500 billion billion electron antineutrinos (one flavour of antineutrino) are emitted from the nuclear reactors every second, and a small number of these interact with the 20 tonnes of gadoliniumdoped liquid scintillator in each detector; the scintillator emits light when it absorbs an energetic particle. The electron antineutrinos interact with protons in the nuclei of the scintillator molecules to produce positrons (antielectrons) and neutrons in a process known as inverse β-decay. Within a few nanoseconds, the positrons produce light by scintillation, and this is detected by an array of photomultiplier tubes, which amplify the incident light.
When a neutron is captured by a gadolinium nucleus embedded in the scintillator, it forms an excited state, which subsequently decays to a more-stable state by emitting a series of 
